Vemurafenib in patients with relapsed refractory multiple myeloma harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study Journal Article

   

Authors:	Raje, N.; Chau, I.; Hyman, D. M.; Ribrag, V.; Blay, J. Y.; Tabernero, J.; Elez, E.; Wolf, J.; Yee, A. J.; Kaiser, M.; Landau, H.; Michot, J. M.; Hollebecque, A.; Veronese, L.; Makrutzki, M.; Pitcher, B.; Puzanov, I.; Baselga, J.
Article Title:	Vemurafenib in patients with relapsed refractory multiple myeloma harboring BRAF(V600) mutations: A cohort of the histology-independent VE-BASKET study
Keywords:	melanoma; bortezomib; dexamethasone; safety; efficacy; multicenter; open-label
Journal Title:	JCO Precision Oncology
Volume:	2
ISSN:	2473-4284
Publisher:	American Society of Clinical Oncology
Date Published:	2018-01-01
Language:	English
ACCESSION:	WOS:000462137100001
DOI:	10.1200/po.18.00070
PROVIDER:	wos
PMCID:	PMC7446434
PUBMED:	32913989
Notes:	Source: Wos

https://synapse.mskcc.org/synapse/works/has_related_data_chk/145853